Patent details

Basic Information

Publication number:

EP2371958

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111709127

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Novel siRNAs and methods of use thereof

French Title of Invention:

Nouveaux ARNsi et procédés d'utilisation de ceux-ci

German Title of Invention:

Neue siRNA und Verfahren zur ihrer Anwendung

SPC Number:

Dates

Filing date:

25/10/2007

Grant date:

19/03/2014

EP Publication Date:

19/03/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/10/2011

EP B1 Publication Date:

19/03/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/10/2020

Expiration date:

25/10/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/10/2007

 

 

Name:

Quark Pharmaceuticals Inc.

Address:

6501 Dumbarton Circle, Fremont, California 94555, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

26/03/2014

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Feinstein Elena

Address:

Israel (IL)

2

Name:

Kalinski Hagar

Address:

Israel (IL)

Priority

1

Priority Number:

854503 P

Priority Date:

25/10/2006

Priority Country:

United States (US)

2

Priority Number:

930493 P

Priority Date:

15/05/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/113;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

21/10/2019

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages